Pilot Testing A Theory-Driven Self-Management Intervention for Chronic Musculoskeletal Pain
CompletedNot applicableNCT05020470
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The proposed randomized control trial will evaluate auricular point acupressure (APA) treatment administered by the participant themselves with the use of a phone app on chronic musculoskeletal pain (CMP) outcomes. This study will randomly assign participants into three groups: (1) Self-guided mAPA (S-mAPA), (2) In-Person Training + mAPA (IP-mAPA), and (3) Usual Care Control (UC). EMA will be used to assess momentary pain outcomes and APA adherence. Data will be collected at pre- (T1), post-completion of intervention (T2), follow-ups at post 1M- (primary endpoint) (T3), 2M (T4), and 3M (secondary endpoint, long-term sustained effect) (T5) for a total of four assessments.
Study details
- Official title
- Pilot Testing A Theory-Driven Self-Management Intervention for Chronic Musculoskeletal Pain
- Conditions
- Interventions
- Device: Virtual Auricular Point Acupressure (APA)
- Other: In-Person Training
- Other: Usual Care
- Sponsor
- Johns Hopkins University
- Start date
- 2021-09-22
- Primary completion
- 2022-08-11
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adults 18 years of age or older. * Receiving outpatient pain treatment for CMP condition (e.g., pain in the back, hip, knee, upper extremity, lower extremity, neck, pelvic, headache/migraine). * Chronic pain ≥ 4 on a scale of 0-10 point numerical pain, persisting for at least 3 months or has resulted in pain on at least half the days in the past 6 months. Exclusion Criteria: * Disease that might confound therapeutic effects or explanation of outcomes, i.e., infection, malignant tumors, or autoimmune diseases. * Severe ear skin issues. * Use of some types of hearing aids (size may obstruct the placement of seeds) * Concurrent major psychiatric disorder (i.e., participant self-report). * Pregnant women will be excluded from the study based on the self-reported data.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05020470